Thomas A. Murray

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

Demetris Yannopoulos, Jason A. Bartos, Ganesh Raveendran et al. · The Lancet · 2020 · 969 citations · Full text

Cardiopulmonary Resuscitation, Cardiovascular Disease, Medicine +8

Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis

Robert N. Foley, David T. Gilbertson, Thomas A. Murray et al. · New England Journal of Medicine · 2011 · 438 citations

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli et al. · New England Journal of Medicine · 2022 · 235 citations · Full text

Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray et al. · The Lancet Healthy Longevity · 2020 · 222 citations · Full text

Disease Risk Assessment, Global Health, Covid-19 Pandemic +7

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

Carolyn T. Bramante, John B. Buse, David Liebovitz et al. · The Lancet Infectious Diseases · 2023 · 209 citations · Full text

Disease Management, Treatment And Prevention, Post-covid-19 Condition +7